These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 21323514)
21. [Diagnosis of Sézary syndrome including cytogenetic studies]. Neumann E; Schmidt M; Stolzmann WM; Brelińska-Peczalska R; Janicka D Przegl Dermatol; 1981; 68(2):199-208. PubMed ID: 7302270 [No Abstract] [Full Text] [Related]
22. Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization. Espinet B; Salido M; Pujol RM; Florensa L; Gallardo F; Domingo A; Servitje O; Estrach T; Garcìa-Muret P; Woessner S; Serrano S; Solé F Haematologica; 2004 Feb; 89(2):165-73. PubMed ID: 15003891 [TBL] [Abstract][Full Text] [Related]
23. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593 [TBL] [Abstract][Full Text] [Related]
24. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome. Scarisbrick JJ; Woolford AJ; Calonje E; Photiou A; Ferreira S; Orchard G; Russell-Jones R; Whittaker SJ J Invest Dermatol; 2002 Mar; 118(3):493-9. PubMed ID: 11874489 [TBL] [Abstract][Full Text] [Related]
25. [Diagnostics of primary cutaneous lymphomas]. Felcht M; Hillen U; Klemke CD Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267 [TBL] [Abstract][Full Text] [Related]
26. A case of bullous Sézary syndrome. Wu S; Jenkins F; Byrd R; Googe PB; Jolly PS Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621681 [TBL] [Abstract][Full Text] [Related]
27. Sézary syndrome without erythroderma. Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000 [TBL] [Abstract][Full Text] [Related]
28. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314 [TBL] [Abstract][Full Text] [Related]
29. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study. Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694 [TBL] [Abstract][Full Text] [Related]
30. Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome. Marks DI; Vonderheid EC; Kurz BW; Bigler RD; Sinha K; Morgan DA; Sukman A; Nowell PC; Haines DS Br J Haematol; 1996 Mar; 92(4):890-9. PubMed ID: 8616082 [TBL] [Abstract][Full Text] [Related]
31. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
32. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome. Limon J; Nedoszytko B; Brozek I; Hellmann A; Zajaczek S; Lubiński J; Mrózek K Cancer Genet Cytogenet; 1995 Aug; 83(1):75-81. PubMed ID: 7656210 [TBL] [Abstract][Full Text] [Related]
33. Complex cytogenetic and immunophenotypic aberrations in a patient with Sezary syndrome. Mohr B; Illmer T; Oelschlägel U; Nowak R; Hölig K; Paaz U; Kroschinsky F; Schuler U; Ehninger G Cancer Genet Cytogenet; 1996 Aug; 90(1):33-6. PubMed ID: 8780744 [TBL] [Abstract][Full Text] [Related]
34. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls]. Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931 [TBL] [Abstract][Full Text] [Related]
35. Cytogenetic study of a patient with the Sézary syndrome. Solé F; Tarrida N; Coll MD; Caballin MR; De Miguel A; Woessner S; Egozcue J Cancer Genet Cytogenet; 1990 Feb; 44(2):193-6. PubMed ID: 2297678 [TBL] [Abstract][Full Text] [Related]
36. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome. Nagler AR; Samimi S; Schaffer A; Vittorio CC; Kim EJ; Rook AH J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074 [TBL] [Abstract][Full Text] [Related]
37. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome. Moerman-Herzog A; Mehdi SJ; Wong HK Cells; 2020 Aug; 9(9):. PubMed ID: 32872487 [TBL] [Abstract][Full Text] [Related]
38. Sézary syndrome-clinical and histopathologic features, differential diagnosis, and treatment. Spicknall KE Semin Cutan Med Surg; 2018 Mar; 37(1):18-23. PubMed ID: 29719016 [TBL] [Abstract][Full Text] [Related]
39. Large cell transformation of Sézary syndrome. A conventional and molecular cytogenetic study. So CC; Wong KF; Siu LL; Kwong YL Am J Clin Pathol; 2000 Jun; 113(6):792-7. PubMed ID: 10874879 [TBL] [Abstract][Full Text] [Related]